Shapiro Medical Group
histogen?
Collapse
X
-
Yes, they needed to raise capital to continue their research. The Series A investment closed this week and they have raised sufficient cash.
I would expect to see some results by the end of 2011 and hopefully something on the market, in Asia at least, by 2014.Comment
-
Comment
-
Where did you read the Histogen was pushing back the clinical trials until Feb 2011. It seemed like only a few months ago the said they were starting in fall 2010. Also where did get the info about additional capital needs and those being met. Everytime I read things like this it just reassures me how far away these type companies really are.Comment
-
Well, I read it somewhere else, in a financial paper I think, but as I can't find that this confirms the same:
Comment
-
I dont know. Something is telling me that article is either fake or old and someone re posted with the current date on the bottom. The only place you can find that article is on that lifestyle.
"The initial close of Series A financing will allow Histogen to maintain timelines for product introductions, including the company's first tissu 317 e engineering products, which are slated for launch in late 2008 and early 2009."Comment
-
Dammit. Good spot though.
Actually, it appears that Histogen are still selling shares. I wonder whether I should buy some. The appreciation might pay for the treatment when it comes out!Comment
-
Comment
-
It is my understanding from the last trial that each participant received only one injection into the scalp. One aspect of the next trial is to work out not only safety, but the optimum dosage. 25% from a single injection is extremely impressive.
Something will be here soon and I'm confident of that. Even if it's a shift in the attitude of society to wigs (e.g. you MUST wear one!), we're too image conscious to allow people to carry on walking around bald for much longer.Comment
-
Histogen raises $10 million
This has already been posted on other sites but in case no one has seen the article the link is below.
Comment
Comment